216 results
Page 2 of 11
SC 14D9
918qu
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
9qaxvhkmscamfn2tz
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-C
EX-99.1
ew0yb0xk3unjbk
31 May 22
Information about tender offer
10:02am
SC14D9C
EX-99.1
ydj mf68az
31 May 22
Written communication relating to third party tender offer
7:55am
8-K
EX-99.1
1jobpsez
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-99.1
knwzl zmb5jmr
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
byl mg1y2zrjy
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
POS AM
7cs99
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
6omfdnnnw rr8bxpfbh2
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
EX-99.1
vyjfvc q84i4w7l6
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
blblo p71m1
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
70xw6udq
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
EX-99.1
erds7 9hspf
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
ncdlvm1a
8 Dec 21
Regulation FD Disclosure
6:55am
8-K/A
EX-99.1
5gmpt8
16 Nov 21
Results of Operations and Financial Condition
6:30am
8-K
EX-99.3
48mteux4he
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.2
ga5l4w iq1i
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am